Multimodal fMRI study of prosyndrome brain network modulation by tDCS treatment in different target areas

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200066999

Enrollment

Unknown

Registered

2022-12-23

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstrual syndrome

Interventions

PMS(DMN) group:Cathodal stimulation with tDCS

PMS(SN)group:Cathodal stimulation with tDCS

PMS(ECN)group:Cathodal stimulation with tDCS

Sham group:Cathodal stimulation with tDCS

HC(DMN):Cathodal stimulation with tDCS

HC(SN):Cathodal stimulation with tDCS

HCECN):Cathodal stimulation with tDCS

SHAM:Cathodal stimulation with tDCS

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: ? meets the diagnostic criteria for PMS; ? with a regular menstrual cycle of 22-35 days; ? age is between 18 and 45 years; combined drug or other clinically related therapy is not allowed during the ? trial; ? normal body mass index (Body Mass Index, BMI).

Exclusion criteria

Exclusion criteria: ? with other mental disorders or drug, alcohol dependence; ? with somatic disease, recent head trauma, severe infection, or surgery; ? lactating or pregnant women; ? with irregular menstrual cycle; ? with other clinical drug observation investigators; ? with a history of smoking; ? patients with polycystic ovary syndrome and endometriosis.

Design outcomes

Primary

Measure	Time frame
DRSP;	—

Secondary

Measure	Time frame
HAMD-17;HAMA-14;PSQI;SF-12;	—

Countries

China

Contacts

Public ContactGaoxiong Duan

The People's Hospital of Guangxi Zhuang Autonomous Region

duangaoxiong@126.com+86 18587740369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026